7 Jan 2009 at 11:40am Akron Biotechnology, LLC announces its 2009 alliances starting with Austin Chemical Company, Inc. , with the intention to expand its reach to the B2B clients in the biotech, pharmaceutical, and diagnostic industries. Austin Chemical provides global ...
Read more...
7 Jan 2009 at 9:45am But in a research note to clients this morning biotech analyst Bill Tanner at Leerink Swann says, ""We believe ELN shares could re-emerge as an attractive opportunity for healthcare investors by virtue of the market's overly aggressive discounting of ...
Read more...
7 Jan 2009 at 8:55am NEW YORK (AP) ? Hefty one-time charges led Supervalu Inc. to post a big loss for its fiscal third quarter on Wednesday, but the grocer beat Wall Street estimates when the special items were excluded from the results. For the quarter ended Nov. 29 ...
Read more...
7 Jan 2009 at 8:48am (page 2 of 2) Putnam recommends 14 top-quality stocks that have fallen by more than 30% in 2008, all leaders in their industries that he figures would make "good foundation" stocks for almost any portfolio. Among them: AT&T ( T ), a dominant telecom ...
Read more...
6 Jan 2009 at 2:26pm Redwood City?s Facet Biotech Corp. ? recently spun off from PDL BioPharma Inc. ? will part with its chief business officer Friday. Facet (NASDAQ: FACTV) said in a Securities and Exchange Commission filing that on Monday it ?determined to ...
Read more...
6 Jan 2009 at 12:38pm LEAWOOD, Kan.--( BUSINESS WIRE )--Madeira Therapeutics announced today that Peter Joiner, Madeira president and chief executive officer, will present an overview of the company at the 2009 Biotech Showcase on January 14, 2009, at 2:45 p.m. Pacific (5 ...
Read more...
6 Jan 2009 at 2:51am Cash is king, and life sciences companies expecting to survive 2009 better have lots of it. With potential investors facing their own liquidity crisis, many biotech, diagnostic and medical device companies are eliminating anything but the quickest ...
Read more...
